Recently, the FDA announced the removal of certain compounded GLP1 ingredients from its drug shortage list. These ingredients are found in: The drug products were in shortage since 2020. The FDA had ...

Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...

Just today, this drug became more widely available. Some product is now facing a recall following an apparent storage error.

A doctor has warned of the potential dangers of a 'game changing' diabetes drug which could rival the likes of Ozempic. The medication - and similar drugs - have been catapulted into the heart of pop ...